Featured News

A new study conducted by researchers at the Cleveland Clinic and presented at the recent American College of Gastroenterology (ACG) meeting is shedding light on just how deeply celiac disease can impact a woman’s reproductive system.

A new study published in the journal Gastro Hep Advances finds that a considerable proportion of Black patients with biopsy-confirmed celiac disease had negative diagnostic blood tests. Traditionally perceived as predominantly affecting non-Hispanic White individuals, this study underscores the importance of bridging existing research gaps to better serve underrepresented populations. 

Using data from the Foundation’s iCureCeliac® Patient Registry, a new observational study helps explain the relationship between persistent celiac disease symptoms, gluten-free diet adherence, mental health, and quality of life.

Chugai Pharmaceutical Co., Ltd. recently published encouraging results from a non-clinical study on DONQ52, an experimental medication for celiac disease. The findings show its potential to block the immune response to gluten in celiac disease without affecting the rest of the immune system.  

Otorhinolaryngological (ORL) – better known as ear, nose, and throat – complaints in celiac disease are considered rare and are often overlooked by physicians. A recent international narrative review analyzed the latest evidence on the association among celiac disease, ORL, and esophageal symptoms. 

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

A recent study published in The Lancet Journal of Gastroenterology & Hepatology sought to determine the accuracy of blood (serological) tests in celiac disease diagnosis in adults. The results of this study are interesting, to say the least.

A recent study evaluated the prevalence of detectable gluten immunogenic peptides (GIPs), which are resistant to digestion and are excreted through the stool and urine, to gauge accidental gluten exposure and adherence to a gluten-free diet in children with celiac disease in the United States.   

Celiac disease world expert Alessio Fasano, MD, recently wrote a commentary on a study that set out to identify a link between inflammatory bowel disease and celiac disease/celiac autoimmunity in children and adults.